期刊文献+

弥散加权成像在95例宫颈腺癌病理分级/分型及临床分期中的应用 被引量:2

Application of Diffusion Weighted Imaging in Pathological Grading/Typing and Clinical Staging of 95 Cases of Cervical Adenocarcinoma
下载PDF
导出
摘要 目的探讨弥散加权成像(DWI)与宫颈腺癌病理分级/分型及临床分期的相关性。方法回顾性收集2011年5月至2018年2月在中国医学科学院肿瘤医院确诊为宫颈腺癌的患者95例,治疗前均行常规MRI及DWI检查,b值取0、800 s/mm^(2),测量宫颈腺癌的表观弥散系数(ADC)均值,比较ADC均值在宫颈腺癌不同分化程度、不同病理类型及不同临床分期中的差异。结果宫颈腺癌低分化组ADC均值为(1.00±0.25)×10^(-3) mm^(2)/s,中分化组ADC均值为(1.09±0.25)×10^(-3) mm^(2)/s,高分化组ADC均值为(1.22±0.20)×10^(-3) mm^(2)/s。低分化组与高分化组病灶ADC均值差异具有统计学意义(P=0.002)。子宫颈管腺癌(普通型)组ADC均值为(1.04±0.24)×10^(-3) mm^(2)/s,黏液腺癌组ADC均值为(1.21±0.26)×10^(-3) mm^(2)/s,两组病灶的ADC均值差异有统计学意义(P=0.005)。结论宫颈腺癌分化程度越差,ADC均值越低。黏液腺癌的ADC均值高于子宫颈管腺癌(普通型)。 Objective To investigate the correlations of diffusion weighted imaging(DWI)with pathological grading,typing and clinical staging of cervical adenocarcinoma.Methods The data of 95 patients with cervical adenocarcinoma from May 2011 to February 2018 in Cancer Hospital Chinese Academy of Medical Sciences were collected for retrospective analysis.Before treatment,conventional MRI and DWI(b=0,800 s/mm^(2))were performed,and the apparent diffusion coefficient(ADC)value of cervical adenocarcinoma was measured.The ADC values were compared among different pathological grades,types,and clinical stages.Results The mean ADC value was(1.00±0.25)×10^(-3) mm^(2)/s in the poorly differentiation group,(1.09±0.25)×10^(-3) mm^(2)/s in the moderately differentiation group,and(1.22±0.20)×10^(-3) mm^(2)/s in the well differentiation group,which showed significant difference between the poorly and well differentiation groups(P=0.002).The mean ADC values were(1.04±0.24)×10^(-3) mm^(2)/s and(1.21±0.26)×10^(-3) mm^(2)/s in the endocervical adenocarcinoma(usual type)group and mucinous carcinoma group,respectively,which showed significant difference(P=0.005).Conclusions The worse differentiation of cervical adenocarcinoma corresponded to the lower ADC value.The ADC value of mucinous carcinoma was higher than that of endocervical adenocarcinoma(usual type).
作者 张洁 赵心明 陈雁 ZHANG Jie;ZHAO Xinming;CHEN Yan(Department of Radiology,National Cancer Center,National Clinical Research Center for Cancer,Cancer Hospital,CAMS and PUMC,Beijing 100021,China)
机构地区 国家癌症中心
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2022年第1期60-64,共5页 Acta Academiae Medicinae Sinicae
关键词 宫颈肿瘤 腺癌 弥散加权成像 cervical neoplasm adenocarcinoma diffusion-weighted imaging
  • 相关文献

参考文献6

二级参考文献45

  • 1林开武,张碧清,薛晓玲.宫颈癌的MRI分期与临床及病理分期对照研究[J].医学影像学杂志,2010,20(12):1853-1855. 被引量:35
  • 2Padhani AR, Husband JE. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies[J].Clin Radiol, 2001, 56 (8): 607-620.
  • 3Jennings D, Raghunand N, Gillies RJ. Imaging hemodynamics [J].Cancer Metastasis Rev, 2008, 27 (4) :589-613.
  • 4Yamashita Y, Baba T, Baba Y, et al. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy[J].Radiology, 2000, 216(3):803-809.
  • 5Bergamino M, Saitta L, Barletta L, et al. Measurement of blood-brain barrier permeability with tl-weighted dynamic contrast-enhanced MR/in brain tumors: a comparative study with two different algorithms[J].ISRN Neurosci, 2013, 2013: 905279.
  • 6Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T (1)-weighted MRI of a diffusable tracer: standardized quantities and symbols[J].J Magn Reson Imaging, 1999, 10(3):223-232.
  • 7Barth PJ, Weingartner K, KShler HH, et al. Assessment of the vascularization in prostatic carcinoma: a morphometric investigation[J].Hum Pathol, 1996, 27 (12): 1306-1310.
  • 8Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging[J].J Magn Reson Imaging, 1997, 7( 1 ):91-101.
  • 9Schlenger K, Hockel M, Mitze M, et al. Tumor vascularity-a novel prognostic factor in advanced cervical carcinoma[J]. Gynecol Oncol, 1995, 59( 1 ):57-66.
  • 10Mayr NA, Yuh WT, Arnholt JC, et al. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer[J].J Magn Reson Imaging, 2000, 12 (6): 1027-1033.

共引文献97

同被引文献14

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部